First Header Logo Second Header Logo

Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.

Seki M, LaCanna R, Powers JC, Vrakas C, Liu F, Berretta R, Chacko G, Holten J, Jadiya P, Wang T, Arkles JS, Copper JM, Houser SR, Huang J, Patel VV, Recchia FA. Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation. J Pharmacol Exp Ther. 2016 09; 358(3):441-9.

View in: PubMed